Nautilus Biotechnology, Inc. (NAUT)

$2.17

-0.17 (-7.26%)
Rating:
Recommendation:
-
Symbol NAUT
Price $2.17
Beta 0.918
Volume Avg. 0.22M
Market Cap 266.745M
Shares () -
52 Week Range 1.86-6.33
1y Target Est -
DCF Unlevered NAUT DCF ->
DCF Levered NAUT LDCF ->
ROE -17.26% Sell
ROA -16.58% Sell
Operating Margin -
Debt / Equity 10.12% Neutral
P/E -
P/B 0.80 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NAUT news


Healthcare
Biotechnology
NASDAQ Global Select

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.